Related Experiment Video
Updated: May 12, 2026
09:51
Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
Autophagy modulation as a target for anticancer drug discovery
Xin Li1, Huai-long Xu, Yong-xi Liu
1School of Life Sciences & State Laboratory of Bio-resources and Eco-environment, Ministry of Education, Sichuan University, Chengdu 610064, China.
Acta Pharmacologica Sinica
|April 9, 2013
Summary
Autophagy, a cellular process, plays a dual role in cancer, acting as both a promoter and suppressor. Understanding its regulation is key to developing novel anticancer therapeutics.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Autophagy is a fundamental cellular process for maintaining homeostasis by degrading damaged components.
- Dysregulation of autophagy is linked to the development and progression of various diseases, notably cancer.
- The complex role of autophagy in cancer presents both challenges and opportunities for therapeutic intervention.
Purpose of the Study:
- To provide a comprehensive overview of autophagy's regulatory mechanisms in cancer.
- To elucidate the dual roles of autophagy as both a promoter and suppressor in cancer progression.
- To discuss current and emerging therapeutic strategies targeting autophagy for cancer treatment.
Main Methods:
- Literature review of regulatory mechanisms of autophagy in cancer.
- Analysis of studies detailing the dual roles of autophagy in cancer.
- Examination of therapeutic agents and strategies that modulate autophagy for anticancer effects.
Main Results:
- Autophagy's role in cancer is context-dependent, acting as either a tumor promoter or suppressor.
- Several agents that modulate autophagy have demonstrated anticancer effects.
- Emerging strategies for targeting autophagy show promise for future cancer drug discovery.
Conclusions:
- Modulating autophagy presents a promising avenue for developing novel anticancer therapeutics.
- Further research into autophagy regulation is crucial for optimizing its clinical application in cancer therapy.
- Targeting autophagy holds potential for creating effective anticancer drugs that meet clinical needs.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...